Prevalence and clinical characteristics associated with left atrial thrombus detection: Apixaban

Table 3 Clinical characteristics and thrombus resolution

Study ID	AC after thrombus identification	Thrombus resolution	Duration of AC (d)	P2Y12 inhibitor	Aspirin	LVEF (%)	LA dilation	Spontaneous contrast	LAA velocity (cm/s)	Duration of A-fib	CHADS-VASc score
Apixaban following index TEE (n = 6)
LA-011	Apixaban	Yes	143	No	No	55	Moderate	None	30.4	Paroxysmal	3
LA-016	Apixaban	Yes	38	Yes	Yes	15	Severe	Severe	14.4	Paroxysmal	2
LA-017	Apixaban	Yes	175	No	Yes	15	Severe	Mild	34.0	Paroxysmal	4
LA-019	Apixaban	Yes	40	No	No	30	Severe	None	26.5	Paroxysmal	2
LA-020	Apixaban	Yes	56	No	Yes	25	Severe	Moderate	28.0	Persistent	3
LA-005	Apixaban	No	112	No	No	65	Moderate	Moderate	49.2	Persistent	4
		5/6	Mean 94.0
		(83.3%)	Median 84.0

AC: Anticoagulation; A-fib: Atrial fibrillation; LA: Left atrium; LAA: Left atrial appendage; LVEF: Left ventricular ejection fraction; TEE: Transesophageal echocardiogram.